But as these products proliferate, manufacturers face a new set of questions. How do expectations around comfort, usability, ...

Senseonics Holdings, Inc. SENS recently presented first-ever real-world evidence for its Eversense 365 continuous glucose ...

Diabetes technology innovators gathered last week for the Advanced Technologies and Treatments for Diabetes Conference (ATTD 2026).

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong fourth-quarter 2025 ...

There was a notable increase in the use of continuous glucose monitors (CGMs) among Medicare Advantage members with Type 2 diabetes from 2021-23.

The integration of wearable biosensors with artificial intelligence and digital health platforms may further expand their capabilities. Future systems could analyze physiological signals in real time, ...

Researchers have created “Smart Underwear,” a wearable device that measures flatulence by detecting hydrogen produced by gut microbes. Early tests suggest people may pass gas about 32 times a day—much ...

New data shows positive real-world impact of the world’s first and only one-year CGM, with a full year of strong patient adherence, glucometrics ...

Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, ...

Abbott has announced results from the FreeDM2 randomised controlled trial (RCT), indicating that improved glucose outcomes were observed in individuals using the FreeStyle Libre c ...

Check out the companies making the biggest moves in premarket trading: Adobe — The software giant saw shares tumble 8%. CEO Shantanu Narayen said that he would step down from his post after a ...

A new study published in the current issue of the Journal of Managed Care & Specialty Pharmacy (JMCP)—conducted by a Humana Healthcare Research team and Dr.